Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEOSTASIS THERAPEUTICS, INC. | 21,100 | reported | 03 Apr 2017 | tx 2+28,600 |
| Kalaris Therapeutics, Inc. | 0 | reported | 20 Mar 2026 | tx 70+493,823−125,203 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | SALE | Kalaris Therapeutics, Inc. | 1,915 | 6.72 USD | |
| 19 Mar 2026 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 60,800 | 0.00 USD | deriv |
| 10 Apr 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 50,262 | 0.00 USD | deriv |
| 26 Mar 2025 | SALE | Kalaris Therapeutics, Inc. | 907 | 8.97 USD | |
| 21 Feb 2025 | SALE | Kalaris Therapeutics, Inc. | 96 | 10.08 USD | |
| 23 Jan 2025 | SALE | Kalaris Therapeutics, Inc. | 4 | 9.94 USD | |
| 23 Jan 2025 | SALE | Kalaris Therapeutics, Inc. | 32 | 9.45 USD | |
| 10 Jan 2025 | SALE | Kalaris Therapeutics, Inc. | 332 | 0.44 USD | |
| 19 Nov 2024 | SALE | Kalaris Therapeutics, Inc. | 554 | 0.55 USD | |
| 05 Nov 2024 | SALE | Kalaris Therapeutics, Inc. | 1,655 | 0.86 USD | |
| 21 Oct 2024 | SALE | Kalaris Therapeutics, Inc. | 479 | 0.78 USD | |
| 22 Oct 2024 | SALE | Kalaris Therapeutics, Inc. | 486 | 0.77 USD | |
| 03 Oct 2024 | SALE | Kalaris Therapeutics, Inc. | 301 | 0.81 USD | |
| 19 Aug 2024 | SALE | Kalaris Therapeutics, Inc. | 544 | 0.76 USD | |
| 05 Aug 2024 | SALE | Kalaris Therapeutics, Inc. | 1,692 | 0.73 USD | |
| 22 Jul 2024 | SALE | Kalaris Therapeutics, Inc. | 481 | 0.74 USD | |
| 19 Jul 2024 | SALE | Kalaris Therapeutics, Inc. | 479 | 0.75 USD | |
| 02 Jul 2024 | SALE | Kalaris Therapeutics, Inc. | 304 | 0.72 USD | |
| 17 May 2024 | SALE | Kalaris Therapeutics, Inc. | 541 | 0.75 USD | |
| 03 May 2024 | SALE | Kalaris Therapeutics, Inc. | 1,597 | 0.80 USD | |
| 19 Apr 2024 | SALE | Kalaris Therapeutics, Inc. | 473 | 0.75 USD | |
| 22 Apr 2024 | SALE | Kalaris Therapeutics, Inc. | 480 | 0.75 USD | |
| 02 Apr 2024 | SALE | Kalaris Therapeutics, Inc. | 281 | 0.77 USD | |
| 20 Feb 2024 | SALE | Kalaris Therapeutics, Inc. | 494 | 0.70 USD | |
| 08 Feb 2024 | SALE | Kalaris Therapeutics, Inc. | 11,150 | 0.67 USD |